[{"Assets_0_Q3_USD":94786000.0,"CommonStockSharesOutstanding_0_Q3_shares":29924589.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-23469000.0,"NetIncomeLoss_3_Q3_USD":-25926000.0,"NetIncomeLoss_1_Q3_USD":-10168000.0,"StockholdersEquity_0_Q3_USD":67531000.0,"Ticker":"COGT","CIK":"1622229","name":"UNUM THERAPEUTICS INC.","OfficialName":"Cogent Biosciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"369716293.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]